A recent outbreak of novel coronavirus (SARS-CoV-2), the causative agent of COVID-19, has spread rapidly all over the world. Human immunodeficiency virus (HIV) is another deadly virus and causes acquired immunodeficiency syndrome (AIDS). Rapid and early detection of these viruses will facilitate early intervention and reduce disease transmission risk. Here, we present an A ll- I n- O ne D ual CRISPR -Cas12a (termed “AIOD-CRISPR”) assay method for simple, rapid, ultrasensitive, one-pot, and visual detection of coronavirus SARS-CoV-2 and HIV virus. In our AIOD CRISPR assay, a pair of crRNAs was introduced to initiate dual CRISPR-Cas12a detection and improve detection sensitivity. The AIOD-CRISPR assay system was successfully utilized to detect nucleic acids (DNA and RNA) of SARS-CoV-2 and HIV with a sensitivity of few copies. Also, it was evaluated by detecting HIV-1 RNA extracted from human plasma samples, achieving a comparable sensitivity with real-time RT-PCR method. Thus, our method has a great potential for developing next-generation point-of-care molecular diagnostics.
Tick species are considered the second leading vector of human diseases. Different ticks can transmit a variety of pathogens that cause various tick-borne diseases (TBD), such as Lyme disease. Currently, it remains a challenge to diagnose Lyme disease because of its non-specific symptoms. Rapid and accurate identification of tick species plays an important role in predicting potential disease risk for tick-bitten patients, and ensuring timely and effective treatment. Here, we developed, optimized, and tested a smartphone-based deep learning algorithm (termed “TickPhone app”) for tick identification. The deep learning model was trained by more than 2000 tick images and optimized by different parameters, including normal sizes of images, deep learning architectures, image styles, and training–testing dataset distributions. The optimized deep learning model achieved a training accuracy of ~90% and a validation accuracy of ~85%. The TickPhone app was used to identify 31 independent tick species and achieved an accuracy of 95.69%. Such a simple and easy-to-use TickPhone app showed great potential to estimate epidemiology and risk of tick-borne disease, help health care providers better predict potential disease risk for tick-bitten patients, and ultimately enable timely and effective medical treatment for patients.